You have free access to this content

Nephrology

Cover image for Vol. 19 Issue 1

January 2014

Volume 19, Issue 1

Pages 1–64

  1. EDITORIAL

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
  2. KHA-CARI GUIDELINE

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
      Cardiovascular disease in patients with chronic kidney disease (pages 3–10)

      Helen Pilmore, Gursharan Dogra, Matthew Roberts, Hiddo J Lambers Heerspink, Toshiharu Ninomiya, Rachel Huxley and Vlado Perkovic

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12148

  3. REVIEW ARTICLE

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
      Overview of lupus nephritis management guidelines and perspective from Asia (pages 11–20)

      Chi Chiu Mok, Desmond YH Yap, Sandra V Navarra, Zhi-hong Liu, Ming-hui Zhao, Liangjing Lu, Tsutomu Takeuchi, Yingyos Avihingsanon, Xue-qing Yu, Elizabeth A Lapid, Lenrore R Lugue-Lizardo, Vasant Sumethkul, Nan Shen, Shun-le Chen, Tak Mao Chan and for the Asian Lupus Nephritis Network (ALNN)

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12136

  4. ACUTE RENAL DISEASE

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
      Andrographolide induced acute kidney injury: Analysis of 26 cases reported in Chinese Literature (pages 21–26)

      Wu-Xing Zhang, Zhi-Min Zhang, Zhi-Qiang Zhang, Yang Wang and Wei Zhou

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12172

      Summary at a Glance

      This is the first description of acute renal failure after intravenous infusion of andrographolide, a component of the Chinese herb, Andrographis paniculata. Acute tubular necrosis is the renal lesion, and patients usually recover with supportive management.

  5. DIALYSIS

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
  6. CLINICAL GLOMERULONEPHRITIS

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
      N-acetylgalactosamine exposure of serum IgA1 was associated with glomerulosclerosis and tubular atrophy/interstitial fibrosis of IgA nephropathy patients (pages 32–39)

      Li-Xia Xu, Zhi-ming Ye, Zhonglin Feng, Gang Xin, Bin Zhang, Shuangxin Liu, Ruizhao Li, Zhilian Li, Xinling Liang and Wei Shi

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12169

      Summary at a Glance

      The authors investigated the associations between the GalNAc exposure of serum IgA1, and clinical parameters and histological manifestations, respectively. They showed that the GalNAc exposure rate more than 0.4 was a risk factor of glomerular sclerosis and tubulointerstitial injury in IgAN. The work is of significant interest to researchers in the area of IgAN.

    2. You have free access to this content
      Probucol combined with valsartan in immunoglobulin A nephropathy: A multi-centre, open labelled, randomized controlled study (pages 40–46)

      Zhiming Ye, Li Zhang, Lixia Xu, Wei Shi, Haitang Hu, Xiaofeng Shi, Weiqiang Zhong, Shuan Hou, Honghong Yan, Bin Zhang, Yunfeng Xia, Wenjian Wang, Zonglin Feng, Liping Wang and Yongzheng Liang

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12177

      Summary at a Glance

      The anti-proteinuric effects of lipid lowering agents, including potential effects that are independent of cholesterol, are unclear. Probucol was shown to be anti-proteinuric in experimental nephritis some years ago. Wei et al. have shown, in a controlled trial, potential adjunctive effects of probucol on early proteinuria in IgA nephropathy when combined with valsartan.

  7. EXPERIMENTAL GLOMERULONEPHRITIS

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
      Mizoribine selectively attenuates monocyte chemoattractant protein-1 production in cultured human glomerular mesangial cell: A possible benefit of its use in the treatment of lupus nephritis (pages 47–52)

      Tomomi Aizawa, Tadaatsu Imaizumi, Kazushi Tsuruga, Shojiro Watanabe, Yuki Chiba, Tomoh Matsumiya, Hidemi Yoshida and Hiroshi Tanaka

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12171

      Summary at a Glance

      This study describes how the immunosuppressant mizoribine selectively inhibits production of MCP-1, but not other chemokines, following TLR3-dependent mesangial cell activation. This may explain the ability of mizoribine to suppress macrophage infiltration in human kidney disease and it raises the possibility of a novel mechanism of action for this drug.

  8. PROGRESSIVE CHRONIC RENAL DISEASE

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
    2. You have free access to this content
      Is lead chelation therapy effective for chronic kidney disease? A meta-analysis (pages 56–59)

      Shi-kun Yang, Li Xiao, Pan-ai Song, Xiao-xuan Xu, Fu-you Liu and Lin Sun

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12162

  9. CORRESPONDENCES

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
      New Onset Psoriasis after Rituximab for Treatment of Idiopathic Membranous Nephropathy (page 60)

      Maggie Ming Yee Mok, Chi Keung Yeung, Daniel Tak Mao Chan and Wai Kei Lo

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12147

    2. You have free access to this content
    3. You have free access to this content
      An unusual case of severe acute tubular necrosis (pages 62–63)

      Madeleine Lily Cameron, Elizabeth Jarvis, Kimberley Oliver and Carmel Hawley

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12163

  10. CORRIGENDUM

    1. Top of page
    2. EDITORIAL
    3. KHA-CARI GUIDELINE
    4. REVIEW ARTICLE
    5. ACUTE RENAL DISEASE
    6. DIALYSIS
    7. CLINICAL GLOMERULONEPHRITIS
    8. EXPERIMENTAL GLOMERULONEPHRITIS
    9. PROGRESSIVE CHRONIC RENAL DISEASE
    10. CORRESPONDENCES
    11. CORRIGENDUM
    1. You have free access to this content
      Corrigendum (page 64)

      Article first published online: 17 DEC 2013 | DOI: 10.1111/nep.12183

      This article corrects:

SEARCH

SEARCH BY CITATION